Effects of Sandostatin on Neuroendocrine Tumours of the Gastrointestinal System
- 1 January 1993
- book chapter
- Published by Springer Nature
- Vol. 129, 45-55
- https://doi.org/10.1007/978-3-642-84956-5_3
Abstract
Before reviewing the effects of Sandostatin on neuroendocrine tumours (NETs) of the gastrointestinal system, it is pertinent to briefly review the clinical features of patients with such tumours.Keywords
This publication has 27 references indexed in Scilit:
- Somatostatin receptors in human cancer: Incidence, characteristics, functional correlates and clinical implicationsThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Octreotide: A Long-Acting Somatostatin AnalogThe Lancet Healthy Longevity, 1990
- Long-Acting Somatostatin Analog Controls Acid and Gastrin Secretion in Benign, Not in Malignant, Zollinger-Ellison SyndromeJournal of Clinical Gastroenterology, 1989
- The Use of SMS 201-995 (Somatostatin Analogue) in InsulinomasHormone Research, 1988
- PREVENTION OF HYPOGLYCAEMIA IN A PATIENT WITH PANCREATIC MICROADENOMATOSIS BY A LONG‐ACTING SOMATOSTATIN ANALOGUE SMS 201‐995Clinical Endocrinology, 1987
- Treatment of Inoperable Glucagonoma with the Long-Acting Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1986
- Long-Term Treatment of a Metastasizing GRFoma with a Somatostatin Analogue (SMS 201-995) in a Girl with GigantismScandinavian Journal of Gastroenterology, 1986
- Evaluation of SMS 201-995 in Gastrointestinal APUDomasScandinavian Journal of Gastroenterology, 1986
- TREATMENT OF METASTASISING GRF-PRODUCING TUMOUR WITH A LONG-ACTING SOMATOSTATIN ANALOGUEThe Lancet, 1984
- Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic choleraDigestive Diseases and Sciences, 1982